Literature DB >> 19912258

A review on the vascular features of the hyperimmunoglobulin E syndrome.

H Yavuz1, R Chee.   

Abstract

Autosomal recessive, autosomal dominant and the sporadic forms of hyperimmunoglobulin E syndrome (HIES) are multi-system disorders. Although HIES patients may present with cold abscesses, the vascular features of HIES are not well recognized. The objective of this review is to characterize the nature and spectrum of vascular abnormalities in HIES patients. Vascular abnormalities in HIES patients were reviewed with Medline and Google Scholar-based searches. In brief, the searches combined terms related to HIES with the terms related to vasculature. Furthermore, reference lists from the original studies and review papers identified were screened. There were vascular abnormalities in 25 patients with HIES. These abnormalities were identified as aneurysms (coronary, aortic, carotid and cerebral), pseudoaneurysms, congenital patent ductus venosus, superior vena cava syndrome, vasculitides, vascular ectasia, thrombosis and others. They may be congenital or acquired, in the veins and arteries, affecting both sexes. These abnormalities can be seen in all subtypes of HIES. They could be also fatal in children and adults. Limited pathological investigations revealed the presence of vasculitis. Three of the patients were found to have overlap diseases. In this review, the spectrum of vascular abnormalities in HIES are documented and discussed in detail for the first time. They highlight a previously under-recognized and potentially devastating complication of these disorders. These vascular abnormalities constitute one of the major clinical characteristics in HIES. The presence of hypereosinophilia, vasculitis and defective angiogenesis in HIES may contribute to the formation of vascular abnormalities in HIES.

Entities:  

Mesh:

Year:  2009        PMID: 19912258      PMCID: PMC2819490          DOI: 10.1111/j.1365-2249.2009.04044.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  35 in total

Review 1.  The hyper-IgE syndrome. Two cases and review of the literature.

Authors:  A Shemer; G Weiss; Y Confino; H Trau
Journal:  Int J Dermatol       Date:  2001-10       Impact factor: 2.736

Review 2.  What does Stat3 do?

Authors:  David E Levy; Chien-kuo Lee
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

3.  Genetic linkage of hyper-IgE syndrome to chromosome 4.

Authors:  B Grimbacher; A A Schäffer; S M Holland; J Davis; J I Gallin; H L Malech; T P Atkinson; B H Belohradsky; R H Buckley; F Cossu; T Español; B Z Garty; N Matamoros; L A Myers; R P Nelson; H D Ochs; E D Renner; N Wellinghausen; J M Puck
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

4.  Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder.

Authors:  B Grimbacher; S M Holland; J I Gallin; F Greenberg; S C Hill; H L Malech; J A Miller; A C O'Connell; J M Puck
Journal:  N Engl J Med       Date:  1999-03-04       Impact factor: 91.245

5.  Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.

Authors:  Guilian Niu; Kenneth L Wright; Mei Huang; Lanxi Song; Eric Haura; James Turkson; Shumin Zhang; Tianhong Wang; Dominic Sinibaldi; Domenico Coppola; Richard Heller; Lee M Ellis; James Karras; Jacqueline Bromberg; Drew Pardoll; Richard Jove; Hua Yu
Journal:  Oncogene       Date:  2002-03-27       Impact factor: 9.867

6.  Th1/Th2 cytokine imbalance in a family with hyper-IgE syndrome.

Authors:  M G Netea; P M Schneeberger; E de Vries; B J Kullberg; J W M van der Meer; M I Koolen
Journal:  Neth J Med       Date:  2002-10       Impact factor: 1.422

7.  Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation.

Authors:  Yoko Yahata; Yuji Shirakata; Sho Tokumaru; Kenshi Yamasaki; Koji Sayama; Yasushi Hanakawa; Michael Detmar; Koji Hashimoto
Journal:  J Biol Chem       Date:  2003-07-21       Impact factor: 5.157

8.  Cytokine imbalance in hyper-IgE syndrome: reduced expression of transforming growth factor beta and interferon gamma genes in circulating activated T cells.

Authors:  Shouichi Ohga; Akihiko Nomura; Kenji Ihara; Yasushi Takahata; Naohiro Suga; Hideki Akeda; Rumiko Shibata; Jun Okamura; Naoko Kinukawa; Toshiro Hara
Journal:  Br J Haematol       Date:  2003-04       Impact factor: 6.998

Review 9.  Pneumatocele complicating hyperimmunoglobulin E syndrome (Job's Syndrome).

Authors:  R C Shamberger; M E Wohl; A Perez-Atayde; W H Hendren
Journal:  Ann Thorac Surg       Date:  1992-12       Impact factor: 4.330

10.  Peripheral blood eosinophilia and eosinophil accumulation in coronary microvessels in acute Kawasaki disease.

Authors:  Masaru Terai; Kumi Yasukawa; Takafumi Honda; Toshiaki Jibiki; Kiyomi Hirano; Junichi Sato; Naruhiko Ishiwada; Masashi Seguchi; Shiro Ueda; Yoichi Kohno
Journal:  Pediatr Infect Dis J       Date:  2002-08       Impact factor: 2.129

View more
  19 in total

1.  Broadening the translational immunology landscape.

Authors:  M Peakman
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

2.  Rheumatologic manifestations of primary immunodeficiency diseases: comment on the study by Dimitriades et al.

Authors:  Bahtiyar Toz; Burak Erer
Journal:  Clin Rheumatol       Date:  2016-05-03       Impact factor: 2.980

3.  IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- mice.

Authors:  Jing Wang; Xiang Cheng; Mei-Xiang Xiang; Mervi Alanne-Kinnunen; Jian-An Wang; Han Chen; Aina He; Xinghui Sun; Yan Lin; Ting-Ting Tang; Xin Tu; Sara Sjöberg; Galina K Sukhova; Yu-Hua Liao; Daniel H Conrad; Lunyin Yu; Toshiaki Kawakami; Petri T Kovanen; Peter Libby; Guo-Ping Shi
Journal:  J Clin Invest       Date:  2011-08-08       Impact factor: 14.808

4.  Three cases of CLIPPERS: a serial clinical, laboratory and MRI follow-up study.

Authors:  O Kastrup; J van de Nes; T Gasser; K Keyvani
Journal:  J Neurol       Date:  2011-05-10       Impact factor: 4.849

5.  Association of eosinophil-to-lymphocyte ratio with coronary slow-flow phenomenon in patients undergoing coronary angiography.

Authors:  Aydın Rodi Tosu; Muhsin Kalyoncuoğlu; Halil İbrahim Biter; Sinem Çakal; Beytullah Çakal; Murat Selçuk; Tufan Çinar
Journal:  Arch Med Sci Atheroscler Dis       Date:  2022-07-07

Review 6.  Primary immunodeficiency diseases associated with neurologic manifestations.

Authors:  Soodabeh Fazeli Dehkordy; Asghar Aghamohammadi; Hans D Ochs; Nima Rezaei
Journal:  J Clin Immunol       Date:  2011-10-26       Impact factor: 8.542

Review 7.  The hyperimmunoglobulin E syndrome--clinical manifestation diversity in primary immune deficiency.

Authors:  Aleksandra Szczawinska-Poplonyk; Zdzislawa Kycler; Barbara Pietrucha; Edyta Heropolitanska-Pliszka; Anna Breborowicz; Karolina Gerreth
Journal:  Orphanet J Rare Dis       Date:  2011-11-15       Impact factor: 4.123

Review 8.  Clinical Manifestation of Hyper IgE Syndrome Including Otitis Media.

Authors:  Jing Wu; Li Hong; Tong-Xin Chen
Journal:  Curr Allergy Asthma Rep       Date:  2018-08-15       Impact factor: 4.919

9.  The Hyper-IgE Syndromes: Lessons in Nature, From Bench to Bedside.

Authors:  Efren L Rael; Robert T Marshall; Jonathan J McClain
Journal:  World Allergy Organ J       Date:  2012-07       Impact factor: 4.084

10.  A new inflammatory marker: elevated eosinophil-tolymphocyte ratio associated with presence and severity of isolated coronary artery ectasia.

Authors:  Mücahid Yilmaz; Hidayet Kayançiçek; Hasan Korkmaz; Nevzat Gözel; Mehmet Nail Bilen; Özlem Seçen; Pinar Öner; Ökkeş Uku; Suat Demirkiran; Yusuf Çekici; Orkun Eroğlu; Kurtoğlu Ertuğrul
Journal:  Cardiovasc J Afr       Date:  2020-10-02       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.